Fluorescent Phase-Changing Perfluorocarbon Nanodroplets as Activatable Near-Infrared Probes.
NIR probes
multimodal imaging
ultrasound-enhanced fluorescence
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Jun 2022
30 Jun 2022
Historique:
received:
20
05
2022
revised:
27
06
2022
accepted:
29
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
The sensitivity of fluorescence imaging is limited by the high optical scattering of tissue. One approach to improve sensitivity to small signals is to use a contrast agent with a signal that can be externally modulated. In this work, we present a new phase-changing perfluorocarbon nanodroplet contrast agent loaded with DiR dye. The nanodroplets undergo a liquid-to-gas phase transition when exposed to an externally applied laser pulse. This results in the unquenching of the encapsulated dye, thus increasing the fluorescent signal, a phenomenon that can be characterized by an ON/OFF ratio between the fluorescence of activated and nonactivated nanodroplets, respectively. We investigate and optimize the quenching/unquenching of DiR upon nanodroplets' vaporization in suspension, tissue-mimicking phantoms and a subcutaneous injection mouse model. We also demonstrate that the vaporized nanodroplets produce ultrasound contrast, enabling multimodal imaging. This work shows that these nanodroplets could be applied to imaging applications where high sensitivity is required.
Identifiants
pubmed: 35806326
pii: ijms23137312
doi: 10.3390/ijms23137312
pmc: PMC9266996
pii:
doi:
Substances chimiques
Contrast Media
0
Fluorocarbons
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Norris Cotton Center
ID : Pilot Project Grant
Organisme : Thayer School of Engineering
ID : Innovation Fellowship
Références
Anticancer Res. 2015 Mar;35(3):1669-74
pubmed: 25750326
ACS Appl Mater Interfaces. 2018 Jan 17;10(2):1534-1543
pubmed: 29276883
Ultrasound Med Biol. 2020 Jun;46(6):1296-1325
pubmed: 32165014
Soft Matter. 2013 Jan 1;9(8):2384-2388
pubmed: 23526919
Future Oncol. 2009 Nov;5(9):1501-11
pubmed: 19903075
Lancet Oncol. 2021 May;22(5):e186-e195
pubmed: 33765422
Theranostics. 2016 Jul 25;6(11):1866-76
pubmed: 27570556
Theranostics. 2018 Jul 16;8(15):4116-4128
pubmed: 30128040
Chem Commun (Camb). 2012 Apr 4;48(27):3262-78
pubmed: 22367463
Langmuir. 2011 Sep 6;27(17):10412-20
pubmed: 21744860
Appl Phys Lett. 2012 Jul 16;101(3):33703
pubmed: 22893732
Bioconjug Chem. 2020 Feb 19;31(2):276-292
pubmed: 31935072
J Nucl Med. 2020 Oct;61(10):1419-1427
pubmed: 32764124
Sci Rep. 2016 Oct 24;6:35942
pubmed: 27775014
J Biomed Opt. 2014 Aug;19(8):085005
pubmed: 25104407
Biomed Opt Express. 2019 Jun 06;10(7):3139-3151
pubmed: 31360596
J Control Release. 2019 Jan 10;293:144-154
pubmed: 30503398
Lancet Oncol. 2018 Oct;19(10):1394-1403
pubmed: 30143441
J Am Chem Soc. 2020 Sep 2;142(35):14789-14804
pubmed: 32786771
Chembiochem. 2018 Dec 18;19(24):2522-2541
pubmed: 30247795
Int J Mol Sci. 2017 Feb 11;18(2):
pubmed: 28208666
Quant Imaging Med Surg. 2021 Mar;11(3):1010-1022
pubmed: 33654673
IEEE J Sel Top Quantum Electron. 2014 May-Jun;20(3):
pubmed: 26052192
Small. 2017 Sep;13(33):
pubmed: 28692762
Sci Rep. 2014 Apr 15;4:4690
pubmed: 24732947